Obesity, lutein metabolism, and age-related macular degeneration: A web of connections

Nutrition Reviews

Volumn 63, Issue 1, 2005, Pages 9-15

  Johnson, Elizabeth J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Lutein; Macular degeneration; Obesity; Zeaxanthin

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN; XANTHOPHYLL; ZEAXANTHIN;

ARTICLE; CIRCULATION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; METABOLISM; NUTRITION; OBESITY; OXIDATIVE STRESS; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

AGE FACTORS; HUMANS; LUTEIN; MACULAR DEGENERATION; OBESITY; ODDS RATIO; OXIDATIVE STRESS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; XANTHOPHYLLS;

EID: 12144264776     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2004.janr.9-15     Document Type: Article

References (66)

1. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62(suppl 6):1448S-1461S.
2. Beatty S, Boulton B, Henson D, Koh HH, Murray IJ. Macular pigment and age related macular degeneration. Br J Ophthalmol. 1999;83:867-877.
3. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med. 1989;7:617-635.
4. Schalch W. Carotenoids in the retina: a review of their possible role in preventing or limiting damage caused by light and oxygen. In: Emerit I, Chance B, eds. Free Radicals and Aging. Basel: Birkhauser Verlag; 1992:280-298.
5. Hammond BR Jr, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:387-406.
6. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Ann Rev Nutr. 2003;23:171-201.
7. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci. 1997;38:1802-1811.
8. Thomson LR, Toyoda Y, Delori FC, et al. Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp Eye Res. 2002;75:529-542.
9. Thomson LR, Toyoda Y, Langner A, et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci. 2002;43:3538-3549.
10. Haegerstrom-Portnoy G. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J Opt Soc Am A. 1988;5:2140-2144.
11. Weiter JJ, Delori F, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol. 1988;106:286-292.
12. Jaffe GJ, Wood IS. Retinal phototoxicity from the operating microscope: a protective effect by the fovea. Arch Ophthalmol. 1988;106:445-446.
13. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci. 2001;42:235-240.
14. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
15. Falsini B, Piccardi M, larossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology. 2003;110:51-60.
16. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometery. 2004;75:216-230.
17. National Center for Chronic Disease Prevention and Health Promotion, Centers of Disease Control and Prevention. U.S. Obesity Trends 1985-2003. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/. Accessed November 17, 2004.
18. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121:785-792.
19. Keaney JF Jr, Larson MG, Vasan RS, et al.; Framington Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-439.
20. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008-2014.
21. Block G, Dietrich M, Norkus EP, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002;156:274-285.
22. Barton M, Carmona R, Morawietz H, et al. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension. 2000;35(1 part 2):329-336.
23. Brasier AR, Recinos A 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22:1257-1266.
24. Trevisan M, Browne R, Ram M, et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol. 2001;154:348-356.
25. Sickel W. Retinal metabolism in dark and light. In: Fuortes MGF, ed. Handbook of Sensory Physiology. Berlin: Springer-Verlag; 1972:667-727.
26. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in the retinal physiology and ocular pathology. Prog Clin Biol Res. 1989;312:95-112.
27. Delmelle M. Retinal sensitized photodynamic damage to liposomes. Photochem Photobiol. 1978;28:357-360.
28. Gaillard ER, Atherton SJ, Eldred G, Dillon J. Photophysical studies on human retinal lipofuscin. Photochem Photobiol. 1995;61:448-453.
29. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sama T. Blue light-induced reactivity of retinal age pigment: in vitro generation of oxygen-reactive species. J Biol Chem. 1995;270:18825-18830.
30. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1995;36:1271-1279.
31. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
32. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol. 1999;6:125-143.
33. Suzuki K, Ito Y, Ochiai J, et al. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev. 2003;4:259-266.
34. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112:1785-1788.
35. Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS. Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exer. 2003;35:1160-1166.
36. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042-1047.
37. Tchernof A, Nolan A, Sites CK, Ades PA, Poelman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002;105:564-569.
38. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961-967.
39. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.
40. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291:704-710.
41. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
42. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 2000;152:1065-1071.
43. Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996;384:240-242.
44. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313(part 1):17-29.
45. Parker RS. Carotenoids in human blood and tissues. J Nutr. 1989;119:101-104.
46. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem. 1990;8:1-10.
47. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
48. Yeum KJ, Booth SL, Roubenoff R, Russell RM. Plasma carotenoid concentrations are inversely correlated with fat mass in older women. J Nutr Health Aging. 1998;2:79-83.
49. Broekmans WM, Berendschot TT, Klopping-Ketelaars IA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr. 2002;76:595-603.
50. Grolier P, Boirie Y, Levadoux E, et al. Age-related changes in plasma lycopene concentration, but not in vitamin E, are associated with fat mass. Br J Nutr. 2000;84:711-716.
51. Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr. 1996;126:128-137.
52. Kuno T, Hozumi M, Morinobu T, Murata T, Mingci Z, Tamai H. Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls. Free Radic Res. 1998;28:81-86.
53. Hammond BR Jr, Ciulla TA, Snodderly DM. Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci. 2002;43:47-50.
54. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001;119:1259-1265.
55. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A. 2004;101:6659-6663.
56. Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB J. 1996;10:542-551.
57. Einer V. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 dietary fatty acids. Trans Am Ophthalmol Soc. 2002;100:301-308.
58. Berkenmeier G, Grosche J, Reichenbach A. Immunocytochemical demonstration of alpha 2-M-R/LRP on Muller (glial) cells isolated from rabbit and human retina. Neuroreport. 1996;8:149-151.
59. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
60. Shanmugaratnam J, Berg E, Kimerer L, et al. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res Mol Brain Res. 1997;59:113-120.
61. US Department of Agriculture. USDA-NCC Carotenoid Database for U.S. Foods-1998. Available at: http://www.nal.usda.gov/fnic/foodcomp/Data/ car98/car98.html. Accessed November 17, 2004.
62. Mares-Perlman JA, Fisher A, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424-432.
63. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80:368-371.
64. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH; POLA Study Group. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249.
65. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study. Age-Related Eye Disease Study Report Numbers. Ophthalmology. 2000;107:2224-2232.
66. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583-587.